"First in Man" Total Percutaneous Aortic Arch Repair With 3-Inner-branch Endografts: A Report of Two Cases.

医学 外科 主动脉弓 经皮 动脉瘤 解剖(医学) 主动脉夹层 支架 体外循环 主动脉瘤 放射科
作者
Justine Mougin,Ron Azogui,Julien Guihaire,Mark R Tyrrell,Gustavo S Oderich,Dominique Fabre,Stéphan Haulon
出处
期刊:Annals of Surgery [Ovid Technologies (Wolters Kluwer)]
卷期号:274 (6): e652-e657
标识
DOI:10.1097/sla.0000000000005167
摘要

Aneurysms of the arch are a complex clinical problem and a technical challenge. Currently, over 40% of patients are considered unfit for conventional open surgery, requiring a cardiopulmonary bypass and hypothermic circulatory arrest. In experienced hands and appropriate anatomic conditions, arch-branched graft technology has shown to be a safe and effective alternative to open conventional surgery to patients that historically have had no surgical options.This report summarizes the first in man implant of a three-vessel arch branch stent graft using a total percutaneous approach without the need for exposure of the cervical arteries-a surgical step with inherent problems and risks.This approach was performed in two consecutive patients, a 66-year-old woman with a chronic post type A dissection 60 mm diameter aneurysm of the aortic arch, and a 72-year-old man with a 70 mm saccular degenerative atheromatous aortic arch aneurysm.Technical success was obtained in both cases. The patients were extubated in the operating theatre. Neither suffered any pre- or postoperative neurological deficits. Both were discharged home after remarkably uneventful hospital stays. There were no access complications. Postoperative computerized tomography scans and ultra-sound confirmed patent supra-aortic branches and completely excluded aneurysms.Our new truly minimally invasive approach demonstrates that it is possible to manage one of the most challenging treatments of aortic pathologies without any surgical incision. Further, evaluation and experience are required to confirm these promising results.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Mic应助科研通管家采纳,获得10
刚刚
ssshs应助科研通管家采纳,获得10
刚刚
Mic应助科研通管家采纳,获得10
刚刚
Mic应助科研通管家采纳,获得10
刚刚
Julezio应助科研通管家采纳,获得10
1秒前
1秒前
zwq完成签到,获得积分10
1秒前
YJ发布了新的文献求助10
2秒前
秦野完成签到,获得积分10
2秒前
东方元语发布了新的文献求助10
3秒前
光亮发卡完成签到,获得积分10
3秒前
3秒前
赵宇完成签到,获得积分10
4秒前
fly发布了新的文献求助30
4秒前
empty010发布了新的文献求助10
5秒前
学术小垃圾完成签到,获得积分10
5秒前
共享精神应助Colin采纳,获得10
5秒前
啦啦啦完成签到,获得积分10
7秒前
Rita发布了新的文献求助10
7秒前
迅速的宛白完成签到,获得积分20
8秒前
打打应助TTT采纳,获得10
8秒前
9秒前
量子星尘发布了新的文献求助10
9秒前
尼古拉斯佩奇完成签到,获得积分10
9秒前
Derik完成签到,获得积分10
9秒前
科研通AI6.2应助欧阳懿采纳,获得10
9秒前
大模型应助Li采纳,获得10
9秒前
星辰大海应助Zzskrrrr采纳,获得10
11秒前
Cryer2401发布了新的文献求助150
11秒前
12秒前
晴雨发布了新的文献求助10
13秒前
empty010完成签到,获得积分20
14秒前
15秒前
zx完成签到,获得积分10
17秒前
清秋完成签到,获得积分10
17秒前
18秒前
18秒前
打打应助敬老院N号采纳,获得10
18秒前
天天快乐应助敬老院N号采纳,获得10
18秒前
彭于晏应助敬老院N号采纳,获得10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 3000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
Principles of town planning : translating concepts to applications 500
Short-Wavelength Infrared Windows for Biomedical Applications 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6061286
求助须知:如何正确求助?哪些是违规求助? 7893720
关于积分的说明 16306243
捐赠科研通 5205118
什么是DOI,文献DOI怎么找? 2784726
邀请新用户注册赠送积分活动 1767323
关于科研通互助平台的介绍 1647373